"Adventist Health is a faith-based, nonprofit integrated health system serving more than 80 communities on the West Coast and Hawaii. Our compassionate and talented team of 37,000 includes associates, medical staff physicians, allied health professionals and volunteers driven in pursuit of one mission: living God's love by inspiring health, wholeness and hope. Together, we are transforming the American healthcare experience with an innovative, yet timeless, whole-person focus on physical, mental, spiritual and social healing."

During the past decade, Saint Helena Hospital conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 45 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 34 clinical trials were completed. i.e. 242.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Helena Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 26 trials, followed by "Alliance for Clinical Trials in Oncology" with 18 trials sponsored, "SWOG Cancer Research Network" with 12 trials sponsored, "Radiation Therapy Oncology Group" with 4 trials sponsored and "Abbott Medical Devices" with 4 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Helena Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 42 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Saint Helena Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Recurrent Breast Carcinoma" (5 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials) and "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials). Many other conditions were trialed in "Saint Helena Hospital" in a lesser frequency.

Most popular intervention types in "Saint Helena Hospital" are "Drug" (61 trials), "Other" (47 trials), "Biological" (32 trials), "Radiation" (19 trials) and "Procedure" (14 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (29 trials), "Paclitaxel" (13 trials), "Quality-of-Life Assessment" (13 trials), "Docetaxel" (11 trials) and "Carboplatin" (9 trials). Other intervention names were less common.

The vast majority of trials in "Saint Helena Hospital" are 67 trials for "All" genders, 10 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Helena Hospital". undefined are not yet recruiting, 17 are recruiting, 33 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 23 completed trials in Saint Helena Hospital, 2 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Helena Hospital, 1 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".